Bone Biologics Corp (NASDAQ:BBLG): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Bone Biologics Corp (NASDAQ:BBLG) last traded at $0.49, down -7.71% from the previous session. Data from the available sources indicates that Bone Biologics Corp (NASDAQ:BBLG) is covered by 1 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]
There is little time left for Bone Biologics Corp (BBLG) to reach its 1-year target estimate. How soon will it surpass it?
Bone Biologics Corp (NASDAQ:BBLG) shares traded 43.62% higher at $0.78 on Wall Street last session. In accordance with the data, 1 analysts cover Bone Biologics Corp (NASDAQ:BBLG). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $7.50 and a low of $7.50, […]